Results of a multicenter study on the efficacy of cortexin in treatment of cognitive dysfunction in children
Observational study · 2018
- What was studied
- 635 children aged 3–7 across four diagnostic groups
- Main finding
- Reports before/after attention, memory and thinking changes across ADHD, speech-delay, perinatal-injury and asthenic/neurotic groups.
Strongest described response · ADHD subgroup aged 3–4, particularly thinking tests · No numerical improvement percentage or untreated comparison in abstract
Reported findings and study design
635 children aged 3–7: ADHD 269, speech delay 215, perinatal-CNS consequences 82, asthenic/neurotic syndrome 69. Ten IM Cortexin injections.
Population or model 635 children aged 3–7 across four diagnostic groups
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Strongest described response | ADHD subgroup aged 3–4, particularly thinking tests | No numerical improvement percentage or untreated comparison in abstract |
Values describe this study and its comparison. Unreported effect sizes and missing denominators have not been inferred.
Source for these results ↗ · Reviewed 2026-10-29
Study limitations and source details
Study limitations
- No untreated control described; diverse conditions must not be treated as one effect.
- Pediatric clinical findings do not establish enhancement or safety in healthy adults.
Source details
Indexed abstract and citation checked via Europe PMC / PubMed; full methods and risk of bias not appraised.
Sources checked
Citation
Zykov VP, Serebrennikova EB, Panchenko TN, Sycheva YB, Presnyakova SN, Mazur EL, Salova MN, Golubeva ES, Khromova SK. Results of a multicenter study on the efficacy of cortexin in treatment of cognitive dysfunction in children Zh Nevrol Psikhiatr Im S S Korsakova 118(3):27-31. PMID 29652302
Study source ↗ · DOI 10.17116/jnevro20181183127-31 · Bibliography entry · Link to this summary